NURO specializes in neurotechnology and is the architect of the non-invasive NUOS product line. With NUOS, any human being, including highly incapacitated patients with akinetic mutism from a stroke, trauma or neurodegeneration can now communicate by brain; instantly and without any surgery of any kind. Over the past 7 years, the NURO team has worked with some of the key clinical leaders in the United States and has received IRB clearance from Northwestern University for research on human subjects, and US FDA clearance under expanded access as the only non-invasive treatment and communication technology available for late-stage neurodegeneration. We are seeking clinical and commercial partnerships with hospitals, rehabilitation clinics, speech language pathologists, occupational therapists and are interested in establishing regional to national commercial distribution agreements in the United States, Canada, the United Kingdom and the Europe.

NURO Corp. Logo



Event details

Date: September 27 - 29, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


3 in total